ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating

  • Dominik Hrebík
    Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic
  • Tibor Füzik
    Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic
  • Mária Gondová
    Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic
  • Lenka Šmerdová
    Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic
  • Athanassios Adamopoulos
    Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic
  • Ondrej Šedo
    Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic
  • Zbyněk Zdráhal
    Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic
  • Pavel Plevka
    Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic

抄録

<jats:title>Significance</jats:title><jats:p>Medical visits and missed days of school and work caused by rhinoviruses cost tens of billions of US dollars annually. Currently, there are no antivirals against rhinoviruses, and the available treatments only treat the symptoms. Here, we present the molecular structure of human rhinovirus 14 in complex with its cellular receptor intercellular adhesion molecule 1. The binding of the virus to its receptor initiates the infection. Knowledge of the structure of the human rhinovirus 14–intercellular adhesion molecule 1 interface and mechanism of interaction provides the basis for the design of compounds that may block the binding of rhinoviruses to receptors and thus prevent infection.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ